Alcon Inc.
ALC | NYSE
$64.87
-$0.17 (-0.26%)
At close: Sep 21, 2026, 4:00 PM ET
$64.87
$0 (0.00%)
After-hours:
Sep 21, 2026, 5:31 PM ET
Company Profile
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Key Executives
| Name | Position |
|---|---|
| David J. Endicott | Chief Executive Officer & Director |
| Ian Bell | Senior Vice President & Chief Operating Officer |
| Timothy C. Stonesifer | Senior Vice President & Chief Financial Officer |
| Daniel Cravens | Vice President of Investor Relations |
| Franck Leveiller | SVP of Global Research & Development and Chief Scientific Officer |
| Kimberly Martin | Senior VP and Chief HR & Corporate Communications |
| Leon Sergio Duplan Fraustro | Senior Vice President & President of Americas |
| Margaret Buckley | Chief Accounting Officer |
| Muru Murugappan | Senior Vice President and Chief Information & Transformation Officer |
| Royce R. Bedward | Senior Vice President, General Counsel & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 10, 2026 | 6-K | Filing |
| May 15, 2026 | SD | Filing |
| May 05, 2026 | 6-K | Filing |
| Apr 02, 2026 | 6-K | Filing |
| Feb 24, 2026 | 6-K | Filing |
| Feb 24, 2026 | 20-F | Filing |
| Feb 24, 2026 | 6-K | Filing |
| Jan 07, 2026 | 6-K | Filing |
| Dec 09, 2025 | DFAN14A | Filing |
| Nov 12, 2025 | 6-K | Filing |
Alcon Inc.
| Country | Switzerland |
| IPO Date | Apr 8, 2019 |
| Industry | Medical - Specialties |
| Sector | Healthcare |
| Employees | 25,000 |
| CEO | David J. Endicott |
Contact Details
Chemin de Blandonnet 8 Geneva,
GE 1214 Switzerland
Stock Details
| Ticker Symbol | ALC |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001167379 |
| CUSIP Number | H01301128 |
| ISIN Number | CH0432492467 |
| SIC Code | 3851 |
Recent News
- 18 days ago / zacks.comIs it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
- 19 days ago / seekingalpha.comAlcon: A Re-Rating In Eyesight
- 27 days ago / businesswire.comAlcon Prices EUR 500 Million Senior Notes Offering
- 1 month ago / seekingalpha.comAlcon: A Strong Company Trading Close To Its Intrinsic Value, Buy
- 1 month ago / seekingalpha.comAlcon Inc. (ALC) Q2 2026 Earnings Call Transcript
- 1 month ago / zacks.comAlcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs
- 1 month ago / reuters.comEye care company Alcon raises profitability outlook, cuts tariff hit estimate
- 1 month ago / zacks.comAlcon (ALC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- 1 month ago / businesswire.comNew Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
- 1 month ago / benzinga.comAecom, Alcon And 3 Stocks To Watch Heading Into Monday
Add to Watchlist
Select watchlists to add or remove ALC